Abacus Health Partner Bed Bath & Beyond Expands Product Offering

- January 14th, 2020

Abacus announced that Bed Bath & Beyond is expanding its distribution of Abacus’ CBD-based products to over 1,000 locations across the US.

Abacus Health Products (CSE:ABCS,OTCQX:ABAHF) announced that Bed Bath & Beyond (NASDAQ:BBBY) is expanding its distribution of Abacus’ cannabidiol (CBD)-based products from approximately 200 stores to over 1,000 locations across the US.

As quoted in the press release:

Bed Bath & Beyond will be offering 12 unique CBDMEDIC SKUs in its stores covering Pain Relief, First Aid (Eczema and Itch & Rash), Foot & Ankle Pain and Skincare (Acne) categories. In addition to the on-shelf placement the products will also be displayed on off-shelf displays utilizing a specially designed 24-unit point-of-sale display including three top-selling CBDMEDIC SKUs: Arthritis Deep Rub Ointment, Back & Neck Ointment and Muscle & Joint Medicated Pain Relief Spray. The off-shelf displays are being rolled out to 780 stores.

With the addition of these locations the CBDMEDIC line of products will be available in over 7,800 retail locations across the United States.

Click here to read the full press release.

Find out what experts are saying about the future of cannabis edibles

 
Read our new report on the 2019 Lift Cannabis Business Conference
 

Get the latest Cannabis Investing stock information